Bind Therapeutics
Get Full AccessDescription
- BIND Therapeutics is a biotechnology company incorporated in 2006; Pfizer acquired substantially all of its assets in 2016. BINDs product candidates were based on proprietary polymeric nanoparticles called ACCURINS®, which are engineered to target specific cells and tissues in the body at sites of disease. ACCURINS®, which continue to be developed with Pfizer, have the potential to achieve therapeutic outcomes not currently possible with conventional treatment modalities.
-
Headquarters:325 Vassar Street , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-491-3400
-
Website: https://www.bindtherapeutics.com
-
Employees:9
-
Revenue:$10 - 50M
-
Legal Name:Bind Therapeutics
-
Bind Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Bind Therapeutics
-
Where are Bind Therapeutics's Headquarters?
Bind Therapeutics's Headquarters are in 325 Vassar Street ,Cambridge,Massachusetts,United States
-
What is Bind Therapeutics's phone number?
Bind Therapeutics's phone number is +1 617-491-3400
-
What is Bind Therapeutics's official website?
Bind Therapeutics's official website is https://www.bindtherapeutics.com
-
What is Bind Therapeutics's Revenue?
Bind Therapeutics's revenue is $10 - 50M
-
What is Bind Therapeutics's NAICS code?
Bind Therapeutics's NAICS code is 325412
-
How many employees are working in Bind Therapeutics
Bind Therapeutics has 9 employees
-
What is Bind Therapeutics's Industry?
Bind Therapeutics is in the industry of Biotechnology

